Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shanshan Liu, Guihong Rong, Xia Li, Lijun Geng, Zhineng Zeng, Dongxiang Jiang, Jun Yang & Yesheng Wei. (2020) Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway. OncoTargets and Therapy 13, pages 5057-5067.
Read now
Read now
Youping Yang, Feng Zhu, Qingmei Wang, Yan Ding, Rongbiao Ying & Linghui Zeng. (2018) Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells. OncoTargets and Therapy 11, pages 8455-8463.
Read now
Read now
Articles from other publishers (34)
Yiqi Yang, Yibo Zhang, Jieqiong Cao, Zijian Su, Fu Li, Peiguang Zhang, Bihui Zhang, Rongzhan Liu, Linhao Zhang, Junye Xie, Jingsheng Li, Jinting Zhang, Xiaojia Chen & An Hong. (2023) FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Qili Liao, Jie Yang, Shengfang Ge, Peiwei Chai, Jiayan Fan & Renbing Jia. (2023) Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs. Journal of Pharmaceutical Analysis 13:2, pages 127-141.
Crossref
Crossref
Junhui Yu, Kui Yang, Jianbao Zheng, Pengwei Zhao, Jie Xia, Xuejun Sun & Wei Zhao. (2022) Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell Death & Disease 13:4.
Crossref
Crossref
Lisa Schuldt, Michael Reimann, Katrin von Brandenstein, Julia Steinmetz, Annika Döding, Ulrike Schulze-Späte, Collin Jacobs & Judit Symmank. (2022) Palmitate-Triggered COX2/PGE2-Related Hyperinflammation in Dual-Stressed PdL Fibroblasts Is Mediated by Repressive H3K27 Trimethylation. Cells 11:6, pages 955.
Crossref
Crossref
Chunling Zhou, Aiping He, Qiang Kang, Chensen Li, Tianzhu Liu, Wenting Cai, Lina Fang & Shuangcheng Ma. (2022) Development of a UPLC–MS/MS method for determination of a dual EZH1/2 inhibitor UNC1999 in rat plasma. Bioanalysis 14:2, pages 67-74.
Crossref
Crossref
Maochao Luo, Xingyue Yang, Hai-Ning Chen, Edouard C. Nice & Canhua Huang. (2021) Drug resistance in colorectal cancer: An epigenetic overview. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188623.
Crossref
Crossref
Daye Yang & Dewei Zhang. (2021) miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis. Clinical and Experimental Medicine 21:4, pages 563-571.
Crossref
Crossref
Yang Li, Gaoxia Yang, Chengcan Yang, Pan Tang, Juncheng Chen, Jifa Zhang, Jie Liu & Liang Ouyang. (2021) Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery. Journal of Medicinal Chemistry 64:16, pages 11798-11815.
Crossref
Crossref
Oliver J. Pickering, Stella P. Breininger, Timothy J. Underwood & Zoë S. Walters. (2021) Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma. Cancers 13:16, pages 4084.
Crossref
Crossref
Merve ÖzelEser KilicMevlüt BaskolHilal AkalınGülden Baskol. (2021)
The Effect of
EZH2
Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism
. Cellular Reprogramming 23:2, pages 139-148.
Crossref
Crossref
Ran Duan, Wenfang Du & Weijian Guo. (2020) EZH2: a novel target for cancer treatment. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Bryson W. Katona, Taylor Hojnacki, Rebecca A. Glynn, Kayla E. Paulosky, Katherine M. Szigety, Yan Cao, Xuyao Zhang, Zijie Feng, Xin He, Jian Ma & Xianxin Hua. (2020) Menin-mediated Repression of Glycolysis in Combination with Autophagy Protects Colon Cancer Against Small-molecule EGFR Inhibitors. Molecular Cancer Therapeutics 19:11, pages 2319-2329.
Crossref
Crossref
Xiao Huo, Hengzi Sun, Qiuhong Qian, Xiangwen Ma, Peng Peng, Mei Yu, Ying Zhang, Jiaxin Yang, Dongyan Cao, Ting Gui & Keng Shen. (2020) CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Zhenyao Chen, Qinnan Chen, Zhixiang Cheng, Jingyao Gu, Wenyan Feng, Tianyao Lei, Jiali Huang, Jiaze Pu, Xin Chen & Zhaoxia Wang. (2020) Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death & Disease 11:10.
Crossref
Crossref
Jingchun Qin, Bin Wen, Yuqi Liang, Weitao Yu & Huixuan Li. (2019) Histone Modifications and their Role in Colorectal Cancer (Review). Pathology & Oncology Research 26:4, pages 2023-2033.
Crossref
Crossref
Thomas L. Clarke, Ran Tang, Damayanti Chakraborty, Capucine Van Rechem, Fei Ji, Sweta Mishra, Anqi Ma, H. Ümit Kaniskan, Jian Jin, Michael S. Lawrence, Ruslan I. Sadreyev & Johnathan R. Whetstine. (2020)
Histone Lysine Methylation Dynamics Control
EGFR
DNA Copy-Number Amplification
. Cancer Discovery 10:2, pages 306-325.
Crossref
Crossref
Paul Peixoto, Céline Grandvallet, Jean-Paul Feugeas, Michaël Guittaut & Eric Hervouet. (2019) Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes. Cells 8:12, pages 1656.
Crossref
Crossref
Danuta Sastre, João Baiochi, Ildercilio Mota de Souza Lima, Felipe Canto de Souza, Amanda Cristina Corveloni, Carolina Hassib Thomé, Vitor Marcel Faça, Josiane Lilian dos Santos Schiavinato, Dimas Tadeu Covas & Rodrigo Alexandre Panepucci. (2019) Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer. BMC Cancer 19:1.
Crossref
Crossref
Da Liu, Xue Meng, Donglu Wu, Zhidong Qiu & Haoming Luo. (2019) A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine. Frontiers in Pharmacology 10.
Crossref
Crossref
Jessica C. Hargarten & Peter R. Williamson. (2018) Epigenetic Regulation of Autophagy: A Path to the Control of Autoimmunity. Frontiers in Immunology 9.
Crossref
Crossref
Paolo Mellini, Biagina Marrocco, Diana Borovika, Lucia Polletta, Ilaria Carnevale, Serena Saladini, Giulia Stazi, Clemens Zwergel, Peteris Trapencieris, Elisabetta Ferretti, Marco Tafani, Sergio Valente & Antonello Mai. (2018) Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1748, pages 20170150.
Crossref
Crossref
Bayley A. Jones, Sooryanarayana Varambally & Rebecca C. Arend. (2018) Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer. Molecular Cancer Therapeutics 17:3, pages 591-602.
Crossref
Crossref
Kathleen W. Clancy, Anna-Maria Russell, Venkataraman Subramanian, Hannah Nguyen, Yuewei Qian, Robert M. Campbell & Paul R. Thompson. (2017) Citrullination/Methylation Crosstalk on Histone H3 Regulates ER-Target Gene Transcription. ACS Chemical Biology 12:6, pages 1691-1702.
Crossref
Crossref
Raushan T. Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev, Katherine Cosmopoulos, Heike Keilhack, Christine R. Klaus, Peter J. Houghton & Malcolm A. Smith. (2017) Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. Pediatric Blood & Cancer 64:3, pages e26218.
Crossref
Crossref
Yu Liu, Ya-Long Wang, Shu-wen He, Ming-Huang Chen, Zhen Zhang, Xian-Pei Fu, Bin-Bin Fu, Bao-Qiong Liao, Yan-Hong Lin, Zhong-Quan Qi & Hai-Long Wang. (2016) Protective effects of resveratrol against mancozeb induced apoptosis damage in mouse oocytes. Oncotarget 8:4, pages 6233-6245.
Crossref
Crossref
Elisabeth Hessmann, Steven A Johnsen, Jens T Siveke & Volker Ellenrieder. (2017) Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?. Gut 66:1, pages 168-179.
Crossref
Crossref
Natalie Grinshtein, Constanza C. Rioseco, Richard Marcellus, David Uehling, Ahmed Aman, Xueqing Lun, Osamu Muto, Lauren Podmore, Jake Lever, Yaoqing Shen, Michael D. Blough, Greg J. Cairncross, Stephen M. Robbins, Steven J. Jones, Marco A. Marra, Rima Al-Awar, Donna L. Senger & David R. Kaplan. (2016) Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. Oncotarget 7:37, pages 59360-59376.
Crossref
Crossref
Antoine Italiano. (2016) Role of the EZH2 histone methyltransferase as a therapeutic target in cancer. Pharmacology & Therapeutics 165, pages 26-31.
Crossref
Crossref
Masaru Katoh. (2016) Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy. Epigenomics 8:2, pages 285-305.
Crossref
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology
3-60
3-63
.
Sanjay Kumar, James A. StokesIIIIII, Udai P. Singh, Kumar S. Bishnupuri & Manoj K. Mishra. 2016. Epigenetic Advancements in Cancer. Epigenetic Advancements in Cancer
229
244
.
Amy V. Paschall & Kebin Liu. (2015) Epigenetic and Immune Regulation of Colorectal Cancer Stem Cells. Current Colorectal Cancer Reports 11:6, pages 414-421.
Crossref
Crossref
Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, Subhasree Nag, Jianwei Zhou & Ruiwen Zhang. (2015) Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications. Medicinal Research Reviews 35:6, pages 1220-1267.
Crossref
Crossref
A. N. Gargalionis, M. V. Karamouzis, C. Adamopoulos & A. G. Papavassiliou. (2015) Protein trafficking in colorectal carcinogenesis--targeting and bypassing resistance to currently applied treatments. Carcinogenesis 36:6, pages 607-615.
Crossref
Crossref